ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

Cisplatin
Bladder, kidney, and other urologic cancers
Gynecologic cancers
Prostate and other male cancers
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

Cisplatin Rx

Generic Name and Formulations:
Cisplatin 1mg/mL; soln for IV infusion after dilution.

Company:
Various generic manufacturers

Therapeutic Use:

Indications for Cisplatin:

As a single agent, for treating transitional cell bladder cancer.

Adult:

Give by IV infusion over 6–8 hours. 50–70mg/m2 IV per cycle once every 3–4 weeks; heavily pretreated patients: initially 50mg/m2 IV per cycle every 4 weeks. Usual max: 100mg/m2 per cycle. Subsequent cycles: give as tolerated, withhold dose if serum creatinine, BUN, platelets, WBCs, or auditory acuity out of normal limits; see literature.

Children:

Not recommended.

Pharmacological Class:

Platinum coordination complex.

Contraindications:

Renal or hearing impairment. Myelosuppression. Pregnancy (Cat.D). Nursing mothers.

Warnings/Precautions:

Have epinephrine, antihistamine available. Monitor baseline and pre-treatment renal function, electrolytes, auditory function; do periodic CBCs (weekly), liver function tests, neurologic exam. Hydrate patient before dosing. Avoid extravasation. Elderly.

Interactions:

Potentiates nephrotoxicity with other nephrotoxic drugs (eg, aminoglycosides). May antagonize anticonvulsants. May be antagonized by pyridoxine.

Adverse Reactions:

Nephrotoxicity, neurotoxicity (eg, peripheral neuropathies), ototoxicity, myelosuppression, hemolytic anemia, marked nausea and vomiting, vascular toxicity (eg, MI, TIA), electrolyte disturbances, hyperuricemia, SIADH, hepatotoxicity, anaphylactic-like reactions, others; see literature.

Note:

Avoid contact with aluminum (eg, needles). Formerly known under the brand name Platinol.

How Supplied:

Contact supplier.

Indications for Cisplatin:

As a single agent, for secondary therapy of metastatic ovarian tumor. Adjunctive therapy for ovarian tumor.

Adult:

Give by IV infusion over 6–8 hours. 100mg/m2 IV per cycle once every 4 weeks; or, (when given with cyclophosphamide): 75–100mg/m2 IV per cycle once every 4 weeks. Usual max: 100mg/m2 per cycle. Subsequent cycles: give as tolerated, withhold dose if serum creatinine, BUN, platelets, WBCs, or auditory acuity out of normal limits; see literature.

Children:

Not recommended.

Pharmacological Class:

Platinum coordination complex.

Contraindications:

Renal or hearing impairment. Myelosuppression. Pregnancy (Cat.D). Nursing mothers.

Warnings/Precautions:

Have epinephrine, antihistamine available. Monitor baseline and pre-treatment renal function, electrolytes, auditory function; do periodic CBCs (weekly), liver function tests, neurologic exam. Hydrate patient before dosing. Avoid extravasation. Elderly.

Interactions:

Potentiates nephrotoxicity with other nephrotoxic drugs (eg, aminoglycosides). May antagonize anticonvulsants. May be antagonized by pyridoxine.

Adverse Reactions:

Nephrotoxicity, neurotoxicity (eg, peripheral neuropathies), ototoxicity, myelosuppression, hemolytic anemia, marked nausea and vomiting, vascular toxicity (eg, MI, TIA), electrolyte disturbances, hyperuricemia, SIADH, hepatotoxicity, anaphylactic-like reactions, others; see literature.

Note:

Avoid contact with aluminum (eg, needles). Formerly known under the brand name Platinol.

How Supplied:

Contact supplier.

Indications for Cisplatin:

Adjunctive therapy for metastatic testicular tumor.

Adult:

Give by IV infusion over 6–8 hours. 20mg/m2 IV daily for 5 days per cycle. Usual max: 100mg/m2 per cycle. Subsequent cycles: give as tolerated, withhold dose if serum creatinine, BUN, platelets, WBCs, or auditory acuity out of normal limits; see literature.

Children:

Not recommended.

Pharmacological Class:

Platinum coordination complex.

Contraindications:

Renal or hearing impairment. Myelosuppression. Pregnancy (Cat.D). Nursing mothers.

Warnings/Precautions:

Have epinephrine, antihistamine available. Monitor baseline and pre-treatment renal function, electrolytes, auditory function; do periodic CBCs (weekly), liver function tests, neurologic exam. Hydrate patient before dosing. Avoid extravasation. Elderly.

Interactions:

Potentiates nephrotoxicity with other nephrotoxic drugs (eg, aminoglycosides). May antagonize anticonvulsants. May be antagonized by pyridoxine.

Adverse Reactions:

Nephrotoxicity, neurotoxicity (eg, peripheral neuropathies), ototoxicity, myelosuppression, hemolytic anemia, marked nausea and vomiting, vascular toxicity (eg, MI, TIA), electrolyte disturbances, hyperuricemia, SIADH, hepatotoxicity, anaphylactic-like reactions, others; see literature.

Note:

Avoid contact with aluminum (eg, needles). Formerly known under the brand name Platinol.

How Supplied:

Contact supplier.

Sign Up for Free e-newsletters